Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New stent graft registry aims to track safety in real patients

NCT ID NCT07279649

First seen Dec 26, 2025 · Last updated Jun 23, 2026 · Updated 25 times

Summary

This registry is following 240 people who receive the GORE VIABAHN VBX stent graft to treat blocked or damaged arteries in the abdomen, pelvis, or limbs. Researchers are tracking how well the device works and any serious side effects over time. The goal is to see if the stent graft performs safely in everyday medical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTO-ILIAC OCCLUSIVE DISEASE (AIOD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • TUM Klinikum

    RECRUITING

    Munich, 81675, Germany

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

GORE VIABAHN VBX balloon expandable stent graft

What this could lead to

If successful, this registry could confirm that the VBX stent graft is safe and effective for treating blocked or damaged arteries in routine practice.

What could go wrong

This is an observational registry, not a controlled trial, so results may be influenced by patient selection and site practices. It does not compare the device to other treatments.

Conditions

The condition(s) this trial relates to.

Aneurysm cardiovascular disorder injury Leriche syndrome peripheral arterial disease peripheral vascular disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.